PENUMBRA INC (PEN) Fundamental Analysis & Valuation

NYSE:PEN • US70975L1070

Current stock price

336.18 USD
+1.19 (+0.36%)
At close:
336.18 USD
0 (0%)
After Hours:

This PEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. PEN Profitability Analysis

1.1 Basic Checks

  • PEN had positive earnings in the past year.
  • PEN had a positive operating cash flow in the past year.
  • Of the past 5 years PEN 4 years were profitable.
  • Of the past 5 years PEN 4 years had a positive operating cash flow.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • PEN's Return On Assets of 9.73% is amongst the best of the industry. PEN outperforms 90.22% of its industry peers.
  • PEN has a Return On Equity of 12.45%. This is amongst the best in the industry. PEN outperforms 87.50% of its industry peers.
  • PEN has a Return On Invested Capital of 8.85%. This is amongst the best in the industry. PEN outperforms 86.41% of its industry peers.
  • PEN had an Average Return On Invested Capital over the past 3 years of 6.23%. This is below the industry average of 9.18%.
  • The 3 year average ROIC (6.23%) for PEN is below the current ROIC(8.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROIC 8.85%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.66%, PEN belongs to the top of the industry, outperforming 85.87% of the companies in the same industry.
  • The Operating Margin of PEN (13.48%) is better than 80.98% of its industry peers.
  • PEN's Operating Margin has improved in the last couple of years.
  • PEN has a better Gross Margin (67.14%) than 72.28% of its industry peers.
  • In the last couple of years the Gross Margin of PEN has grown nicely.
Industry RankSector Rank
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PEN Health Analysis

2.1 Basic Checks

  • PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PEN has been increased compared to 1 year ago.
  • PEN has more shares outstanding than it did 5 years ago.
  • PEN has a better debt/assets ratio than last year.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 21.81 indicates that PEN is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 21.81, PEN belongs to the top of the industry, outperforming 96.74% of the companies in the same industry.
  • The Debt to FCF ratio of PEN is 0.13, which is an excellent value as it means it would take PEN, only 0.13 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.13, PEN belongs to the top of the industry, outperforming 92.39% of the companies in the same industry.
  • PEN has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of PEN (0.01) is better than 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Altman-Z 21.81
ROIC/WACC0.88
WACC10.05%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • PEN has a Current Ratio of 6.64. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 6.64, PEN belongs to the top of the industry, outperforming 83.70% of the companies in the same industry.
  • PEN has a Quick Ratio of 4.29. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • PEN has a Quick ratio of 4.29. This is in the better half of the industry: PEN outperforms 75.54% of its industry peers.
Industry RankSector Rank
Current Ratio 6.64
Quick Ratio 4.29
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. PEN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.80% over the past year.
  • The Earnings Per Share has been growing by 84.42% on average over the past years. This is a very strong growth
  • PEN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.50%.
  • PEN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.16% yearly.
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%

3.2 Future

  • PEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.81% yearly.
  • PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.43% yearly.
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue Next Year14.66%
Revenue Next 2Y14.13%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. PEN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 87.55, the valuation of PEN can be described as expensive.
  • Based on the Price/Earnings ratio, PEN is valued a bit cheaper than 64.67% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. PEN is valued rather expensively when compared to this.
  • The Price/Forward Earnings ratio is 65.73, which means the current valuation is very expensive for PEN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 65.76% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of PEN to the average of the S&P500 Index (23.84), we can say PEN is valued expensively.
Industry RankSector Rank
PE 87.55
Fwd PE 65.73
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 64.67% of the companies in the same industry are more expensive than PEN, based on the Enterprise Value to EBITDA ratio.
  • PEN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PEN is cheaper than 70.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF 75.41
EV/EBITDA 59.56
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
  • PEN has an outstanding profitability rating, which may justify a higher PE ratio.
  • PEN's earnings are expected to grow with 28.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.64
PEG (5Y)1.04
EPS Next 2Y30.32%
EPS Next 3Y28.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PEN Dividend Analysis

5.1 Amount

  • PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PEN Fundamentals: All Metrics, Ratios and Statistics

PENUMBRA INC

NYSE:PEN (3/13/2026, 8:04:00 PM)

After market: 336.18 0 (0%)

336.18

+1.19 (+0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners95.21%
Inst Owner Change1.37%
Ins Owners2.96%
Ins Owner Change0.99%
Market Cap13.19B
Revenue(TTM)1.40B
Net Income(TTM)177.69M
Analysts69.57
Price Target365.95 (8.86%)
Short Float %4.92%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.62%
Min EPS beat(2)4.22%
Max EPS beat(2)5.02%
EPS beat(4)4
Avg EPS beat(4)9.18%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)10.88%
EPS beat(12)12
Avg EPS beat(12)25.19%
EPS beat(16)15
Avg EPS beat(16)21.43%
Revenue beat(2)2
Avg Revenue beat(2)3.54%
Min Revenue beat(2)3.05%
Max Revenue beat(2)4.03%
Revenue beat(4)4
Avg Revenue beat(4)2.83%
Min Revenue beat(4)1.67%
Max Revenue beat(4)4.03%
Revenue beat(8)7
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)1.44%
Revenue beat(16)12
Avg Revenue beat(16)1.32%
PT rev (1m)0.48%
PT rev (3m)14.61%
EPS NQ rev (1m)-0.19%
EPS NQ rev (3m)-0.33%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)0.29%
Revenue NQ rev (1m)0.2%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE 87.55
Fwd PE 65.73
P/S 9.4
P/FCF 75.41
P/OCF 55.27
P/B 9.24
P/tB 10.51
EV/EBITDA 59.56
EPS(TTM)3.84
EY1.14%
EPS(NY)5.11
Fwd EY1.52%
FCF(TTM)4.46
FCFY1.33%
OCF(TTM)6.08
OCFY1.81%
SpS35.77
BVpS36.38
TBVpS31.97
PEG (NY)2.64
PEG (5Y)1.04
Graham Number56.07
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.45%
ROCE 11.52%
ROIC 8.85%
ROICexc 13.24%
ROICexgc 15.72%
OM 13.48%
PM (TTM) 12.66%
GM 67.14%
FCFM 12.46%
ROA(3y)5.5%
ROA(5y)3.35%
ROE(3y)7.13%
ROE(5y)4.35%
ROIC(3y)6.23%
ROIC(5y)4.07%
ROICexc(3y)8.66%
ROICexc(5y)5.61%
ROICexgc(3y)10.48%
ROICexgc(5y)6.87%
ROCE(3y)8.11%
ROCE(5y)5.29%
ROICexgc growth 3Y198.14%
ROICexgc growth 5YN/A
ROICexc growth 3Y208.33%
ROICexc growth 5YN/A
OM growth 3Y165.54%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.05%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.13
Debt/EBITDA 0.1
Cap/Depr 364.77%
Cap/Sales 4.54%
Interest Coverage 250
Cash Conversion 115.45%
Profit Quality 98.45%
Current Ratio 6.64
Quick Ratio 4.29
Altman-Z 21.81
F-Score7
WACC10.05%
ROIC/WACC0.88
Cap/Depr(3y)169.98%
Cap/Depr(5y)143.68%
Cap/Sales(3y)2.58%
Cap/Sales(5y)2.57%
Profit Quality(3y)413.32%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.8%
EPS 3Y182.68%
EPS 5Y84.42%
EPS Q2Q%21.65%
EPS Next Y33.19%
EPS Next 2Y30.32%
EPS Next 3Y28.35%
EPS Next 5Y23.81%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y18.33%
Revenue growth 5Y20.16%
Sales Q2Q%22.14%
Revenue Next Year14.66%
Revenue Next 2Y14.13%
Revenue Next 3Y13.9%
Revenue Next 5Y13.43%
EBIT growth 1Y58.26%
EBIT growth 3Y214.22%
EBIT growth 5YN/A
EBIT Next Year67.7%
EBIT Next 3Y32.58%
EBIT Next 5Y26.71%
FCF growth 1Y18.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.66%
OCF growth 3YN/A
OCF growth 5YN/A

PENUMBRA INC / PEN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to PEN.


What is the valuation status of PENUMBRA INC (PEN) stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


Can you provide the profitability details for PENUMBRA INC?

PENUMBRA INC (PEN) has a profitability rating of 8 / 10.


Can you provide the expected EPS growth for PEN stock?

The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 33.19% in the next year.